Kala Bio, Inc. (KALA)
0.1901
0.00 (0.00%)
USD |
NASDAQ |
Oct 23, 16:00
0.192
0.00 (0.00%)
After-Hours: 20:00
Kala Bio EPS Diluted (Quarterly) : -21.32 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -21.32 |
| March 31, 2026 | -0.1365 |
| December 31, 2025 | 1.232 |
| September 30, 2025 | -53.70 |
| June 30, 2025 | -85.64 |
| March 31, 2025 | -1.410 |
| December 31, 2024 | -87.07 |
| September 30, 2024 | -1.934 |
| June 30, 2024 | -3.161 |
| March 31, 2024 | -4.197 |
| December 31, 2023 | -3.180 |
| September 30, 2023 | -3.413 |
| June 30, 2023 | -4.361 |
| March 31, 2023 | -6.986 |
| December 31, 2022 | -27.82 |
| September 30, 2022 | 19.25 |
| June 30, 2022 | -19.08 |
| March 31, 2022 | -22.37 |
| December 31, 2021 | -34.24 |
| September 30, 2021 | -21.62 |
| June 30, 2021 | -28.27 |
| March 31, 2021 | -24.66 |
| Date | Value |
|---|---|
| December 31, 2020 | -27.33 |
| September 30, 2020 | -24.94 |
| June 30, 2020 | -20.92 |
| March 31, 2020 | -26.93 |
| December 31, 2019 | -31.46 |
| September 30, 2019 | -33.91 |
| June 30, 2019 | -35.16 |
| March 31, 2019 | -37.47 |
| December 31, 2018 | -37.94 |
| September 30, 2018 | -31.71 |
| June 30, 2018 | -30.00 |
| March 31, 2018 | -23.00 |
| December 31, 2017 | -1150.00 |
| September 30, 2017 | -28.00 |
| June 30, 2017 | -23250.00 |
| March 31, 2017 | -20.18 |
| June 30, 2016 | -1016.72 |
| March 31, 2016 | -10.86 |
| December 31, 2015 | -10.16 |
| September 30, 2015 | -9.660 |
| December 31, 2014 | -10.64 |
| September 30, 2014 | -10.70 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.581M |
| Total Expenses (Quarterly) | 1.581M |
| Enterprise Value | -3.552M |
| Earnings Yield | -38.89K% |
| Normalized Earnings Yield | -51664.39 |